Qualitest Hydrocodone, Acetaminophen Tablets Recalled for Improper Doseage

Qualitest issued a voluntary recall for 101 lots of hydrocodone bitartrate and acetaminophen tablets because some tablets could contain higher doses than marked and result in patient liver toxicity, according to the American Society of Anesthesiologists.

Advertisement
By: Staff

Recalled lots were distributed from Feb. 20 to Nov. 19 to wholesale distributors and national retail pharmacies.

Taking a higher dose of hydrocodone could increase severity or frequency of side effects, such as sedation or respiratory depression.

More Articles on Anesthesia:
Southern Medical Association Names Anesthesiologist President
Locale Anesthesia Conversion Factors Released From CMS
CareFusion Release Anesthesia Systems With More Patient Protections

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.